4.6 Article

Leukocyte presence does not increase microbicidal activity of Platelet-rich Plasma in vitro

Journal

BMC MICROBIOLOGY
Volume 15, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12866-015-0482-9

Keywords

Platelet-rich plasma; Leukocytes; Bacterial growth inhibition; Antimicrobial activity; Microbicidal proteins; Nosocomial infections

Categories

Funding

  1. Rizzoli Orthopaedic Institute (Ricerca Corrente) [5x1000]
  2. University of Bologna (RFO funds)
  3. Italian Ministry of Health [1498841]
  4. Emilia-Romagna Region (Region-University Program : Regenerative Medicine of Cartilage and Bone)

Ask authors/readers for more resources

Background: Human platelets are a rich reservoir of molecules that promote regenerative processes and microbicidal activity. This activity might be increased by concentration in platelet-rich plasma (PRP) products and modulated by the presence of leukocytes. Despite extensive use in clinical procedures, only few studies have investigated PRP's real microbicidal potential. Therefore, this study aimed at comparing the in vitro microbicidal activity of platelets and leukocyte-enriched PRP (L-PRP) to pure platelet-rich plasma (P-PRP) and the contribution of leukocytes to microbicidal properties. Antimicrobial effects of P-and L-PRP were tested against Escherichia Coli, Staphylococcus Aureus, Klebsiella Pneumoniae, Pseudomonas Aeruginosa and Enterococcus Faecalis. Furthermore, L-PRP was frozen (L-PRP cryo) to assess whether the preparation maintained in vitro characteristics. Microbicidal proteins released by the three preparations were also evaluated. Results: L-PRP, L-PRP cryo and P-PRP generally induced comparable bacterial growth inhibition for up to 4 h' incubation, range 1-4 log. MIP-1 alpha, RANTES, GRO-alpha, IL-8, NAP-2, SDF-1 alpha and IL-6 showed strong microbicidal potential. Conclusions: We found in vitro antibacterial activity of L-PRP and P-PRP and the possibility to cryopreserve L-PRP, without important changes to its effectiveness; similar microbicidal activity between preparations containing or not leukocytes; and the contribution of three new molecules (NAP-2, SDF-1a and IL-6).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available